Home › Core › ISCC-IDs › 28CrXbFZDR3n7

View ISCC-ID

Core Data

28CrXbFZDR3n7
ISCC-ID - digital asset identifier
CCjLz4mje9ZxZ-CT1EWMBd41SbG-CDj7jAuEePhoR-CRFSfH3awp9xt
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

clinical and cost effectiveness of paclitaxel docetaxel gemcitabine and vinorelbine in nonsmall cell lung cancer a systematic re

Ledger Reference

coblo
Source Ledger/Blockchain
590095
N-th ISCC Decleration on source ledger
32762f051ab4d1af427bce0b593a7d841ecfe0703b40eaa974a7016f43446efe
Hash of block that includes the ISCC-DECLARATION
7260c6fb72ba069ea64bf6d5e00fd7a325743f4970ffbd692c16e245971563c6
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "A Clegg", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://thorax.bmj.com/content/57/1/20.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "BMJ", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1136/thorax.57.1.20", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCjLz4mje9ZxZ-CT1EWMBd41SbG-CDj7jAuEePhoR-CRFSfH3awp9xt", "propertyID": "ISCC"}], "datePublished": "2002-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close